Medically reviewed by Andrew Greenberg, MDMedically reviewed by Andrew Greenberg, MD Presbyopia makes it difficult to see ...

You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...

The "Myopia and Presbyopia Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Age-related macular degeneration affects your central vision but leaves your peripheral vision unchanged. It's a leading ...

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in patients with ...

Shares of LENZ Therapeutics jumped after the company said the Phase 3 trial of its presbyopia treatment in China met its primary endpoint for improving visual acuity. Presbyopia refers to the loss ...

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on developing the first and only aceclidine-based eye drop to improve near vision in people with presbyopia. In this China ...

The VEGA-3 Phase 3 trial evaluating Phentolamine Ophthalmic Solution 0.75% for the treatment of presbyopia is also enrolling patients. Top-line results are expected in the first half of 2025. The ...

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on developing the first and only aceclidine-based eye drop to improve near vision in people with presbyopia. In this China ...